Hands-on Training for Sterile and Non-Sterile Manufacturing Excellence
- Baltimore, MD
Join IVT’s 7th Annual Microbiology Week to gain training on issues facing the microbiology lab in both sterile and non-sterile manufacturing facilities. Hear the about innovative ways of implementing rapid methods, learn how to manage mold manifestations, develop risk-based approaches to improve processes and create a template for CAPAs through root cause analysis. All of the tools gained from attending Microbiology Week will help you prepare for your next FDA or regulatory inspection.
Content Highlights for 2019:
- Improve processes for Microbiological testing in sterile and
non-sterile environments - Develop a robust risk-based environmental monitoring program
- Navigate the European Annex 1 updates and determine how this affects sterility assurance across the bio/pharma industry
- Compare and contrast various rapid methods to determine the best one for your lab
- Prepare a financial justification including ROI, value analysis and more to propose to decision-makers
- Update testing processes for new and changing equipment
- Implement a complete CAPA system through root cause analysis
FEATURED TOPIC: Gain Insight on 2019 Trends — What is New in Microbiology?
Jeanne Moldenhauer,
President
Excellent Pharma Consulting, Inc.
Previous Attendee Acclaim:
The conference is a good meeting-ground for microbiologists from different companies to discuss –
Senior Manager, Microbiology & Aseptic Technique, Fresenius Kabi AB
and learn more about – important topics for industry.
The conference provided a good networking experience and useful knowledge on innovative
QC Bioanalytical, Leidos Biomedical Research Inc.
and current trends in the industry.
I always love all the topics and discussions during this conference. Always entertaining and full of information.
Microbiology Supervisor, Teligent Pharma, Inc.
Great overview of all currently relevant aspects of
Specialist, Manufacturing & Quality CoE Microbiology, Merck
non-sterile and sterile production in pharma.
7th Annual Microbiology Week
Hands-on Training for Sterile and Non-Sterile Manufacturing Excellence
Join IVT’s 7th Annual Microbiology Week to gain training on issues facing the microbiology lab in both sterile and non-sterile manufacturing facilities. Hear the about innovative ways of implementing rapid methods, learn how to manage mold manifestations, develop risk-based approaches to improve processes and create a template for CAPAs through root cause analysis. All of the tools gained from attending Microbiology Week will help you prepare for your next FDA or regulatory inspection.
Content Highlights for 2019:
- Improve processes for Microbiological testing in sterile and
non-sterile environments - Develop a robust risk-based environmental monitoring program
- Navigate the European Annex 1 updates and determine how this affects sterility assurance across the bio/pharma industry
- Compare and contrast various rapid methods to determine the best one for your lab
- Prepare a financial justification including ROI, value analysis and more to propose to decision-makers
- Update testing processes for new and changing equipment
- Implement a complete CAPA system through root cause analysis
FEATURED TOPIC: Gain Insight on 2019 Trends — What is New in Microbiology?
Jeanne Moldenhauer,
President
Excellent Pharma Consulting, Inc.
Previous Attendee Acclaim:
The conference is a good meeting-ground for microbiologists from different companies to discuss –
Senior Manager, Microbiology & Aseptic Technique, Fresenius Kabi AB
and learn more about – important topics for industry.
The conference provided a good networking experience and useful knowledge on innovative
QC Bioanalytical, Leidos Biomedical Research Inc.
and current trends in the industry.
I always love all the topics and discussions during this conference. Always entertaining and full of information.
Microbiology Supervisor, Teligent Pharma, Inc.
Great overview of all currently relevant aspects of
Specialist, Manufacturing & Quality CoE Microbiology, Merck
non-sterile and sterile production in pharma.